On Tuesday, Shares of Quantum Corp (NYSE:QTM), lost -5.13% to $1.11.
Quantum Corp., declared that CEO Jon Gacek and CFO Linda Breard are planned to take part in the following forthcoming investor conferences:
2015 Drexel Hamilton Telecom, Media and Technology Conference
Date: Wednesday, Sept. 9, 2015
Location: The W Hotel, New York, New York
Presentation Time: 9:40 a.m. EDT (6:40 a.m. PDT)
Presenter and Hosting One-on-One Investor Meetings: CEO Jon Gacek
Quantum Corporation provides scale-out storage, archive, and data protection solutions for small businesses to major enterprises in the Americas, Europe, and the Asia Pacific. Its scale-out storage portfolio comprises StorNext software, appliances and full systems called StorNext Pro Solutions, in addition to Lattus extended online storage and Q-Cloud Archive services.
Shares of Simon Property Group Inc (NYSE:SPG), declined -2.33% to $175.15, during its last trading session.
Simon Property Group declared that its popular Chicago Premium Outlets opened an additional 250,000 square feet of outdoor shopping space, significantly increasing the footprint of one of the country’s iconic outlet centers.
New stores in addition to popular existing brands expanded their presence at Chicagoland’s largest and most successful outlet center. Coach, Cole Haan, Guess Factory Store, Michael Kors, Nike Factory Store, Skechers, Under Armour, and Vera Bradley have all raised their space at Chicago Premium Outlets to meet customer demand. Shoppers will also find exciting new selections from sought-after retailers counting Saks Fifth Avenue Off 5th, Columbia Sportswear, UGG Australia, Vince, and the first Midwest outlet stores for eclectic lifestyle designer Robert Graham and Clarins luxury skincare.
The new section of the center comprises fireplaces, art installations and a feature pond, together with the addition of 2,200 parking spaces and new amenities. Conpresently with the exciting expansion, the first phase is undergoing a complete renovation counting an updated Food Court, new pedestrian walkways, landscaping, lighting, seating, and signage.
Simon Property Group, Inc. is an equity real estate investment trust. The firm invests in the real estate markets across the globe. It engages in investment, ownership, administration, and development of properties.
At the end of Tuesday’s trade, Shares of Incyte Corporation (NASDAQ:INCY), lost -0.92% to $115.12.
Incyte Corporation declared it will present at the following investor conferences during the month of September:
- Morgan Stanley 2015 Global Healthcare Conference on Thursday, September 17, 2015 at 12:20 pm (EDT) in New York; and
- Bank of America Merrill Lynch Global Healthcare Conference 2015 on Thursday, September 17, 2015 at 1:45 pm (BST) in London
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. It offers JAKAFI, an oral janus associated kinase (JAK) inhibitor for the treatment of patients with intermediate or high-risk myelofibrosis (MF), counting primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF.
Finally, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), ended its last trade with -2.73% loss, and closed at $124.04.
Vertex and the University of Massachusetts, declared the recipients of the annual Vertex Science Leaders Scholarship, a four-year scholarship to pursue their education in Science, Technology, Engineering and Math (STEM) at any UMass campus. The annual scholarship is part of a broad program developed by Vertex to enhance STEM education for Boston’s youth.
This year’s recipients are two students from Excel High School.
- Cankang Wu plans to study engineering at UMass Amherst. Cankang emigrated with his family from China and will be the first to attend college. As a child he developed an early interest in engineering and technology after spending his days at his father’s wood-processing factory.
- Gladynel Baez will attend UMass Boston to study biology and has aspirations of becoming a doctor. She was inspired to pursue a career in science after losing two aunts and her grandfather to cancer and spending time in Vertex’s Learning Lab.
Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF); and advancing its research and early-stage development programs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
